Recent advances in the pathophysiology of asthma
- PMID: 20525652
- DOI: 10.1378/chest.09-1895
Recent advances in the pathophysiology of asthma
Abstract
There has been an increased understanding, over the past 2 decades, that asthma is a chronic, immunologically mediated condition with a disturbance of the normal airway repair mechanism, which results in inflammatory changes and airway remodeling. The airway inflammation and remodeling together likely explain the clinical manifestations of asthma. The mechanisms by which the external environmental cues, together with the complex genetic actions, propagate the inflammatory process that characterize asthma are beginning to be understood. There is also an evolving awareness of the active participation of structural elements, such as the airway epithelium, airway smooth muscle, and endothelium, in this process. In tandem with this has come the realization that inflammatory cells respond in a coordinated, albeit dysfunctional manner, via an array of complex signaling pathways that facilitate communication between these cells; these structural elements within the lung and the bone marrow serve as reservoirs for and the source of inflammatory cells and their precursors. Although often viewed as separate mechanistic entities, so-called innate and acquired immunity often overlap in the propagation of the asthmatic response. This review examines the newer information on the pathophysiologic characteristics of asthma and focuses on papers published over the past 3 years that have helped to improve current levels of understanding.
Similar articles
-
Function of the airway epithelium in asthma.J Biol Regul Homeost Agents. 2012 Jan-Mar;26(1 Suppl):S41-8. J Biol Regul Homeost Agents. 2012. PMID: 22691249 Review.
-
Airway remodeling in asthma: update on mechanisms and therapeutic approaches.Curr Opin Pulm Med. 2018 Jan;24(1):56-62. doi: 10.1097/MCP.0000000000000441. Curr Opin Pulm Med. 2018. PMID: 29076828 Review.
-
What's new in asthma pathophysiology and immunopathology?Expert Rev Respir Med. 2010 Oct;4(5):605-29. doi: 10.1586/ers.10.57. Expert Rev Respir Med. 2010. PMID: 20923340 Review.
-
Remodeling in asthma.J Allergy Clin Immunol. 2011 Sep;128(3):451-62; quiz 463-4. doi: 10.1016/j.jaci.2011.04.047. Epub 2011 Jun 2. J Allergy Clin Immunol. 2011. PMID: 21636119 Review.
-
Airway structural components drive airway smooth muscle remodeling in asthma.Proc Am Thorac Soc. 2009 Dec;6(8):683-92. doi: 10.1513/pats.200907-056DP. Proc Am Thorac Soc. 2009. PMID: 20008876 Review.
Cited by
-
Basophils as a primary inducer of the T helper type 2 immunity in ovalbumin-induced allergic airway inflammation.Immunology. 2014 Jun;142(2):202-15. doi: 10.1111/imm.12240. Immunology. 2014. PMID: 24383680 Free PMC article.
-
Changes in Serum MicroRNAs after Anti-IL-5 Biological Treatment of Severe Asthma.Int J Mol Sci. 2021 Mar 30;22(7):3558. doi: 10.3390/ijms22073558. Int J Mol Sci. 2021. PMID: 33808110 Free PMC article.
-
Large-scale profiling of signalling pathways reveals an asthma specific signature in bronchial smooth muscle cells.Oncotarget. 2016 May 3;7(18):25150-61. doi: 10.18632/oncotarget.7209. Oncotarget. 2016. PMID: 26863634 Free PMC article.
-
Fluticasone Induces Epithelial Injury and Alters Barrier Function in Normal Subjects.J Steroids Horm Sci. 2014 Jun 11;5(2):26351. doi: 10.4172/2157-7536.1000134. J Steroids Horm Sci. 2014. PMID: 25324978 Free PMC article.
-
Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.Part Fibre Toxicol. 2017 Nov 21;14(1):45. doi: 10.1186/s12989-017-0228-y. Part Fibre Toxicol. 2017. PMID: 29157272 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous